$ENPH
Enphase Energy, Inc. Stock $enph

$enph Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000146310114000011 Filed on May 07, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$82.00M	$57.58M	$45.58M
YoY Change	40.98%	26.34%	6.99%
Cost Of Revenue	$55.17M	$38.93M	$33.38M
YoY Change	31.73%	16.63%	0.25%
Gross Profit	$26.83M	$18.66M	$12.20M
YoY Change	64.78%	52.9%	31.09%
Gross Profit Margin	32.72%	32.4%	26.77%
Selling, General & Admin	$18.17M	$15.35M	$12.89M
YoY Change	36.72%	19.15%	19.93%
% of Gross Profit	67.73%	82.31%	105.61%
Research & Development	$11.15M	$9.086M	$9.026M
YoY Change	31.4%	0.66%	15.1%
% of Gross Profit	41.55%	48.71%	73.98%
Depreciation & Amortization	$2.000M	$1.910M	$1.660M
YoY Change	17.65%	15.06%	53.0%
% of Gross Profit	7.45%	10.24%	13.61%
Operating Expenses	$29.32M	$24.44M	$21.91M
YoY Change	34.65%	11.54%	17.89%
Operating Profit	-$2.488M	-$5.785M	-$9.711M
YoY Change	-54.69%	-40.43%	4.64%
Interest Expense	$486.0K	$449.0K	$464.0K
YoY Change	0.41%	-3.23%	-68.63%
% of Operating Profit
Other Income/Expense, Net	-$428.0K	-$342.0K	-$513.0K
YoY Change	-45.2%	-33.33%	-38.86%
Pretax Income	-$2.916M	-$6.127M	-$10.22M
YoY Change	-53.51%	-40.07%	1.04%
Income Tax	$115.0K	$109.0K	$182.0K
% Of Pretax Income
Net Earnings	-$3.031M	-$6.236M	-$10.41M
YoY Change	-52.61%	-40.07%	2.18%
Net Earnings / Revenue	-3.7%	-10.83%	-22.83%
Basic Earnings Per Share
Diluted Earnings Per Share	-$70.42K	-$146.9K	-$253.0K
COMMON SHARES
Basic Shares Outstanding	42.61M shares	42.24M shares	41.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.60M	$39.90M	$36.40M
YoY Change	10.59%	9.62%	14.11%
Cash & Equivalents	$37.62M	$39.94M	$36.43M
Short-Term Investments
Other Short-Term Assets	$5.600M	$4.300M	$2.500M
YoY Change	107.41%	72.0%	8.7%
Inventory	$15.72M	$14.11M	$22.31M
Prepaid Expenses
Receivables	$46.54M	$28.45M	$24.91M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$105.5M	$86.78M	$86.14M
YoY Change	21.66%	0.74%	17.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.13M	$24.81M	$25.28M
YoY Change	-0.06%	-1.87%	11.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.486M	$1.570M	$1.641M
YoY Change	-1.78%	-4.33%	-77.52%
Total Long-Term Assets	$26.61M	$26.38M	$26.92M
YoY Change	-0.15%	-2.02%	-10.56%
TOTAL ASSETS
Total Short-Term Assets	$105.5M	$86.78M	$86.14M
Total Long-Term Assets	$26.61M	$26.38M	$26.92M
Total Assets	$132.1M	$113.2M	$113.1M
YoY Change	16.53%	0.08%	9.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.51M	$9.353M	$9.057M
YoY Change	94.86%	3.27%	-63.48%
Accrued Expenses	$18.98M	$13.58M	$18.52M
YoY Change	-1.89%	-26.69%	74.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.805M	$3.370M	$2.440M
YoY Change	-16.64%	38.11%	-54.81%
Total Short-Term Liabilities	$51.96M	$34.10M	$31.09M
YoY Change	52.89%	9.68%	-46.59%
LONG-TERM LIABILITIES
Long-Term Debt	$3.726M	$4.457M	$8.046M
YoY Change	-42.95%	-44.61%	-71.67%
Other Long-Term Liabilities	$1.357M	$1.272M	$352.0K
YoY Change	244.42%	261.36%	-97.11%
Total Long-Term Liabilities	$5.083M	$5.729M	$8.398M
YoY Change	-26.6%	-31.78%	-79.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$51.96M	$34.10M	$31.09M
Total Long-Term Liabilities	$5.083M	$5.729M	$8.398M
Total Liabilities	$94.93M	$76.72M	$64.96M
YoY Change	37.58%	18.11%	-34.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$162.2M	-$159.2M	-$137.4M
YoY Change	12.78%	15.82%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.15M	$36.44M	$48.11M
YoY Change
Total Liabilities & Shareholders Equity	$132.1M	$113.2M	$113.1M
YoY Change	16.53%	0.08%	9.35%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$3.031M	-$6.236M	-$10.41M
YoY Change	-52.61%	-40.07%	2.18%
Depreciation, Depletion And Amortization	$2.000M	$1.910M	$1.660M
YoY Change	17.65%	15.06%	53.0%
Cash From Operating Activities	-$200.0K	$4.281M	-$6.972M
YoY Change	-80.0%	-161.4%	-50.45%
INVESTING ACTIVITIES
Capital Expenditures	-$2.100M	$2.172M	$1.682M
YoY Change	16.67%	29.13%	-63.47%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.100M	-$2.172M	-$1.682M
YoY Change	16.67%	29.13%	-63.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$866.0K	$591.0K
YoY Change		46.53%	-82.02%
Cash From Financing Activities	-100.0K	-$412.0K	-$28.00K
YoY Change	-133.33%	1371.43%	-97.12%
NET CHANGE
Cash From Operating Activities	-200.0K	$4.281M	-$6.972M
Cash From Investing Activities	-2.100M	-$2.172M	-$1.682M
Cash From Financing Activities	-100.0K	-$412.0K	-$28.00K
Net Change In Cash	-2.400M	$1.697M	-$8.682M
YoY Change	-4.0%	-119.55%	-55.81%
FREE CASH FLOW
Cash From Operating Activities	-$200.0K	$4.281M	-$6.972M
Capital Expenditures	-$2.100M	$2.172M	$1.682M
Free Cash Flow	$1.900M	$2.109M	-$8.654M
YoY Change	137.5%	-124.37%	-53.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	enph	Increase Decreasein Product Warranty Accrual IncreaseDecreaseinProductWarrantyAccrual	2557000	USD
CY2014Q1	enph	Increase Decreasein Product Warranty Accrual IncreaseDecreaseinProductWarrantyAccrual	296000	USD
CY2014Q1	enph	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8860000	USD
CY2014Q1	enph	Line Of Credit Number Of Debt Agreements LineOfCreditNumberOfDebtAgreements	3	debt_agreement
CY2014Q1	enph	Product Warranty Accrual Accretion Expense ProductWarrantyAccrualAccretionExpense	20000	USD
CY2013Q1	enph	Product Warranty Accrual Accretion Expense ProductWarrantyAccrualAccretionExpense	0	USD
CY2014Q1	enph	Product Warranty Accrual Current Fair Value Disclosure ProductWarrantyAccrualCurrentFairValueDisclosure	126000	USD
CY2013Q4	enph	Product Warranty Accrual Current Fair Value Disclosure ProductWarrantyAccrualCurrentFairValueDisclosure	0	USD
CY2014Q1	enph	Product Warranty Accrual Noncurrent Fair Value Disclosure ProductWarrantyAccrualNoncurrentFairValueDisclosure	461000	USD
CY2013Q4	enph	Product Warranty Accrual Noncurrent Fair Value Disclosure ProductWarrantyAccrualNoncurrentFairValueDisclosure	0	USD
CY2013Q1	enph	Product Warranty Accrual Other ProductWarrantyAccrualOther	0	USD
CY2014Q1	enph	Product Warranty Accrual Other ProductWarrantyAccrualOther	-4000	USD
CY2014Q1	enph	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisedin Period Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedinPeriodFairValue	1100000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	9353000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7363000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32084000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28450000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14780000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13578000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	229000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	230000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192916000	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	195383000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1435000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2013000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2000000	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2026000	USD
CY2013Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	108000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	102000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9514000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8486000	shares
CY2014Q1	us-gaap	Assets Assets	113160000	USD
CY2013Q4	us-gaap	Assets Assets	116669000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	86781000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	90509000	USD
CY2013Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	490000	USD
CY2014Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	497000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38190000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39935000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36434000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45294000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1745000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42123000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42354000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42123000	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42354000	shares
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2014Q1	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications of prior year's balances have been made to conform to current year presentation, including separately presenting balances for "Warranty obligations" in current liabilities on the condensed consolidated balance sheet and under changes in operating assets and liabilities on the condensed consolidated statements of cash flow.</font></div></div>
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6235000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10584000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	33376000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	38925000	USD
CY2014Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	109000	USD
CY2013Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	182000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1900000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2773000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	11284000	USD
CY2014Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	12064000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1910000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1660000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	48000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-178000	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	20800000	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y0M0D
CY2013Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2014Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-6000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6526000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6036000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	12201000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	18655000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5785000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9711000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6127000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10224000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.15
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.25
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	109000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	182000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1159000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3316000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3608000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2835000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-93000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	976000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2467000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2466000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	355000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	977000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	464000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	449000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3507000	USD
CY2014Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4457000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5170000	USD
CY2014Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12197000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15152000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	16580000	USD
CY2013Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	5170000	USD
CY2014Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	4457000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-412000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2172000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1682000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4281000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6972000	USD
CY2014Q1	us-gaap	Inventory Net InventoryNet	14113000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1428000	USD
CY2014Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1916000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	76463000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	76722000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116669000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	113160000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	34095000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33365000	USD
CY2014Q1	us-gaap	Loans Payable Current LoansPayableCurrent	3370000	USD
CY2013Q4	us-gaap	Loans Payable Current LoansPayableCurrent	3507000	USD
CY2014Q1	us-gaap	Long Term Debt LongTermDebt	7827000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	8677000	USD
CY2014Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3370000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-6236000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-10406000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-513000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-342000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	24440000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	21912000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1272000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1570000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1307000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-178000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1154000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-49000	USD
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	107000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1682000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2172000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3655000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4283000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	603000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	454000	USD
CY2014Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	30728000	USD
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	23895000	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	30432000	USD
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	21338000	USD
CY2013Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4942000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	5894000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	6801000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	24834000	USD
CY2013Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	25490000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	17094000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1400000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	2051000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24809000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24853000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	26000	USD
CY2013Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2013Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	40000	USD
CY2014Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2014Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	866000	USD
CY2013Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	591000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9026000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9086000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159175000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152939000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	57580000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	45577000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.25
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6850000	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8828000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1435000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2013000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	83000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.53
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	228000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	30400000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8509000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.94
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.05
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8452000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.82
CY2013Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	968000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1733000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1474000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	613000	USD
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	202000	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	40206000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	36438000	USD
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events, and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. Significant estimates and assumptions reflected in the financial statements include revenue recognition, inventory valuation and accrued warranty obligations. Actual results could differ from those estimates.</font></div></div>
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41149000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42205000	shares
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001463101
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42613014	shares
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	Enphase Energy, Inc.

Files In Submission

Name	View Source	Status
0001463101-14-000011-index-headers.html	Edgar Link	pending
0001463101-14-000011-index.html	Edgar Link	pending
0001463101-14-000011.txt	Edgar Link	pending
0001463101-14-000011-xbrl.zip	Edgar Link	pending
enph-20140331.xml	Edgar Link	completed
enph-20140331.xsd	Edgar Link	pending
enph-20140331_cal.xml	Edgar Link	unprocessable
enph-20140331_def.xml	Edgar Link	unprocessable
enph-20140331_lab.xml	Edgar Link	unprocessable
enph-20140331_pre.xml	Edgar Link	unprocessable
enph0331201410-q.htm	Edgar Link	pending
enph03312014ex311.htm	Edgar Link	pending
enph03312014ex312.htm	Edgar Link	pending
enph03312014ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENPH
Enphase Energy, Inc. Stock $enph

2014 Q2 Form 10-Q Financial Statement

#000146310114000011 Filed on May 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENPH Enphase Energy, Inc. Stock $enph

2014 Q2 Form 10-Q Financial Statement

#000146310114000011 Filed on May 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENPH
Enphase Energy, Inc. Stock $enph